![Anders Månsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 24 488 $ al 30/06/2026
Anders Månsson is currently Chief Executive Officer & Director at Mr. Månsson Business Development AB, Chief Executive Officer at Iconovo AB since 2025, Chairman at CanImGuide Therapeutics AB since 2017, and Independent Director at EQL Pharma AB since 2022.
Former roles include Chief Executive Officer at LIDDS AB from 2022 to 2023, Chief Business Officer & Deputy CEO at RhoVac AB in 2019, Chief Executive Officer at Phase Holographic Imaging AB from 2024 to 2025, Chief Executive Officer at RhoVac ApS from 2019 to 2025, Chief Executive Officer at Oncoinvent ASA (Old) from 2023 to 2024, Director at Respiratorius AB, Independent Director at Amniotics AB from 2021 to 2022, and Vice President & Head-Global Business Development at LEO Pharma A from 2011 to 2017.
Education includes an undergraduate degree from the University of Lund in 1997 and an MBA from Business School Lausanne in 2007.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EQL PHARMA AB 0,03 % | 31/03/2025 | 10.000 ( 0,03 % ) | 24 488 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EQL PHARMA AB | Director/Miembro de la Junta | 23/08/2018 |
| ICONOVO AB | Director Ejecutivo | 31/10/2025 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Presidente | 01/06/2017 |
Anders Månsson Business Development AB | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
RhoVac ApS
 RhoVac ApS Pharmaceuticals: MajorHealth Technology Manufactures medicines for cancers | Director Ejecutivo | 01/02/2025 |
| PHASE HOLOGRAPHIC IMAGING PHI AB | Director Ejecutivo | 01/02/2025 |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Director Ejecutivo | 01/09/2024 |
| LIDDS AB | Director Ejecutivo | 01/08/2023 |
| AMNIOTICS AB | Director Ejecutivo | 01/01/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 14 |
|---|---|
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phase Holographic Imaging AB
 Phase Holographic Imaging AB BiotechnologyHealth Technology Develops and manufactures imaging microscopes and cell analyzers | Health Technology |
EQL Pharma AB
 EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs to treat chronic obstructive pulmonary disease and asthma | Health Technology |
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
LIDDS AB
 LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer | Health Technology |
Business School Lausanne
 Business School Lausanne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
Iconovo AB
 Iconovo AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that manufactures and wholesales powder-based inhalation drugs and devices | Health Technology |
RhoVac ApS
RhoVac ApS Pharmaceuticals: MajorHealth Technology Manufactures medicines for cancers | Health Technology |
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology Engages in the research and development of immunotherapy for therapeutic cancer vaccines | Health Technology |
Amniotics AB
 Amniotics AB BiotechnologyHealth Technology Develops stem cell-based therapeutics for the treatment of human diseases | Health Technology |
Anders Månsson Business Development AB |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
